Acute myocardial infarction is now considered more treatable than ever. However, despite optimized reperfusion, modern pharmacotherapies and improved care systems, one risk remains that is underestimated in many clinical procedures: the development of new heart failure after surviving an infarction. A recent analysis by a large US healthcare system shows that post-infarction heart failure occurs more frequently than a new myocardial infarction – and significantly affects the prognosis of those affected.
You May Also Like
- Treatment of type 2 diabetes: paradigm shift continues
Cardiorenal organ protection is increasingly coming to the fore
- Semaglutide and tirzepatide in HFpEF and T2D/obesity
Prospect of improved cardiovascular prognosis
- Case report: alveolar sarcoidosis
Acute hypoxemic respiratory failure as initial manifestation
- "Swiss Health Care Atlas"
Supply situation in Switzerland: Update
- Lung cancer
Multidisciplinary teams in oncology
- Adrenogenital syndrome
Clinical care from birth to adulthood
- Psoriasis: System therapies in everyday practice
Current real-world data at a glance
- Omega-3 fatty acids for obesity and type 2 diabetes